MedPath

ong term outcomes of intravitreous aflibercept injections for agerelated macular degeneratio

Not Applicable
Conditions
Age-related macular degeneration
Registration Number
JPRN-UMIN000024419
Lead Sponsor
Department of Ophthalmology Protective care for Sensory Disorders, Nagoya University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who diagnosed central serous chorioretinopathy CSC or any other vitreo-retinal diseases.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Best corrected visual acuity, retinal structure, choroidal structure, and adverse event.
Secondary Outcome Measures
NameTimeMethod
umber of IAI.
© Copyright 2025. All Rights Reserved by MedPath